Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants

Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants

Item
http://www.wikidata.org/entity/Q27024346
Neonatal drug therapy: The first frontier of therapeutics for children204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The NetherlandsRegulatory science needs for neonates: a call for neonatal community collaboration and innovationClinical Pharmacology Studies in Critically Ill Children.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenTailored tools to improve pharmacotherapy in infants.Drug development challenges and strategies to address emerging and resistant fungal pathogens.Drugs for rare disorders.Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates.Collaboration in Regulatory Science to Facilitate Therapeutic Development for Neonates.Useful pharmacodynamic endpoints in children: selection, measurement, and next steps.Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases.
P2860

Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants

Item
http://www.wikidata.org/entity/Q27024346
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Strategic biomarkers for drug ...... seases in neonates and infants
@ast
Strategic biomarkers for drug ...... seases in neonates and infants
@en
Strategic biomarkers for drug ...... seases in neonates and infants
@nl
type
label
Strategic biomarkers for drug ...... seases in neonates and infants
@ast
Strategic biomarkers for drug ...... seases in neonates and infants
@en
Strategic biomarkers for drug ...... seases in neonates and infants
@nl
prefLabel
Strategic biomarkers for drug ...... seases in neonates and infants
@ast
Strategic biomarkers for drug ...... seases in neonates and infants
@en
Strategic biomarkers for drug ...... seases in neonates and infants
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P921
P932
P356
P1433
P1476
Strategic biomarkers for drug ...... seases in neonates and infants
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P921
P932